This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

New App Available From ChemotherapyAdvisor.com

NEW YORK, Dec. 24, 2012 /PRNewswire/ --  ChemotherapyAdvisor.com announces the launch of a free app designed specifically for oncology healthcare providers. The app, available now from the iTunes App Store and Google Play, will help the oncology treatment team stay up-to-date with a more convenient way to access information on the latest cancer news and features, concise drug information, continuing medical education (CME) activities, and live coverage from major conferences.

The ChemotherapyAdvisor.com app allows users to:

  • Access the latest oncology news by cancer type
  • Review our cancer treatment regimens
  • View CME activities in a convenient mobile format
  • Read expert interviews and commentary from our expert Advisory Board
  • Search a comprehensive database of oncology drug information
  • Keep up-to-date with weekly blogs and full-length feature articles
  • Take Case Study quizzes to learn about unusual oncology cases and compare responses with their peers
  • View medical slideshows with striking clinical images along with accurate and concise descriptions
  • Use clinical charts and calculators

"Our goal is to provide our subscribers with the latest oncology information and treatment strategy options to help ensure exceptional patient care," said Madonna Krawczyk, Director of Clinical Communications at ChemotherapyAdvisor.com. "We've brought the same outstanding clinical content from our website to a convenient, easy-to-use application that can be accessed at any time through a smartphone or tablet."

Haymarket Media Inc. teamed up with US Biomedical Information Systems (USBMIS) to develop the app, which is available for Apple iOS (iPhone, iPad, iPod touch) and can be downloaded at the iTunes App Store. An Android version is available on Google Play and Amazon. More information is available at ChemotherapyAdvisor.com.

About Haymarket Media Inc.

Haymarket Media Inc. (HMI) is a global publication and communications company, with operations on five continents. Founded in 1957 and headquartered in the United Kingdom, HMI publishes titles in 23 languages in more than 100 nations. In the United States HMI publishes, among other healthcare journals, the Monthly Prescribing Reference (MPR), the MPR Hematology-Oncology Edition, and Oncology Nurse Advisor. Since 1985, MPR has been the most widely used drug reference by healthcare professionals in a wide variety of specialties and practice settings. 

SOURCE Haymarket Media Inc.

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,162.99 +121.45 0.67%
S&P 500 2,123.48 +19.28 0.92%
NASDAQ 5,106.5930 +73.8420 1.47%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs